American Thyroid Association's 2014 Van Meter Award Lecture delivered by Megan Haymart

The American Thyroid Association (ATA) is pleased to announce that the 2017 Van Meter Award recipient is IHPI member Megan Haymart, MD, Assistant Professor of Medicine at U-M, Ann Arbor. The Van Meter Award recognizes outstanding contributions to research on the thyroid gland or related subjects by an investigator who is age 45 or under. At the ATA annual meeting in Victoria, British Columbia, Dr. Haymart will deliver the Van Meter Lecture at 8:05 am on October 19, 2017. Her lecture is titled “Implications of Diagnosing  Low-Risk Thyroid Cancer.” The award winner is kept secret until the time of the lecture.

Dr. Haymart received her MD from the Johns Hopkins University School of Medicine. She completed an internship in Internal Medicine at Johns Hopkins Hospital and a fellowship in Endocrinology, Diabetes, and Metabolism at the University of Wisconsin.

Since joining the ATA in 2007, Dr. Haymart has donated a great deal of time and enthusiasm to the ATA, serving on the Public Health Committee (2010−12) and the Finance and Audit Committee (2012−18), which she now chairs.  She participated in Strategic Planning for the ATA in 2012; and has attended every annual meeting since 2006.   She serves on the editorial boards of Thyroid and Journal of Clinical Endocrinology and Metabolism (JCEM) and is an associate editor of VideoEndocrinology.  She is currently a candidate for the ATA Board of Directors.  In addition, she is a member of the Endocrine Society’s Annual Meeting Steering Committee.

In the eight years since she began her independent career at the University of Michigan, Dr. Haymart has earned a reputation as one of the national leaders in thyroid clinical research. She has recently secured two major research grants, one to study the role of patient and physician perceptions in treatment decision-making in thyroid cancer care, and the other to study incidental thyroid cancer discovery and strategies to minimize over-diagnosis and over-treatment. Both are critical issues for the field.